FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895516423> ?p ?o ?g. }

• W2895516423 endingPage "240" @default.
• W2895516423 startingPage "235" @default.
• W2895516423 abstract "To evaluate the efficacy of maintenance apatinib after chemotherapy for extensive-stage (ED) small-cell lung cancer (SCLC). This was a retrospective analysis of 23 cases of extensive-stage SCLC admitted to the Affiliated Cancer Hospital of Zhengzhou University from January 2015 to December 2017. The patients without progression after induction chemotherapy received apatinib 250 mg per day until disease progression or unacceptable toxicity occurred. We analyzed the median progression-free survival (PFS), median overall survival (OS) and safety. Of 23 enrolled patients, 1 was lost to follow-up. The median PFS from the time of maintenance therapy was 4.1 months (95% CI 3.63–4.57 months). The median PFS from the time of induction chemotherapy was 8.3 months (95% CI 7.20–9.40 months). The median OS from the time of maintenance therapy was 12.5 months (95% CI 5.51–19.49 months). The median OS from the time of induction chemotherapy was 17.0 months (95% CI 9.86–24.14 months). The most frequent treatment-related adverse events were hand–foot syndrome (43.5%, 10/23) and secondary hypertension (30.4%, 7/23), followed by fatigue, proteinuria, nausea, and oral mucositis (17.4%, 13.0%, 13.0%, and 8.7%, respectively). Hematologic toxicity included thrombocytopenia (30.4%), leucopenia (26.1%), and anemia (17.4%). The main grade 3 or 4 toxicities were hand–foot syndrome (8.7%, 2/23) and hypertension (4.3%, 1/23). Maintenance apatinib was safe and achieved encouraging PFS and OS in extensive-stage SCLC." @default.
• W2895516423 created "2018-10-12" @default.
• W2895516423 creator A5021186573 @default.
• W2895516423 creator A5035483620 @default.
• W2895516423 creator A5041685966 @default.
• W2895516423 creator A5055466296 @default.
• W2895516423 creator A5064970901 @default.
• W2895516423 creator A5073304157 @default.
• W2895516423 creator A5078996494 @default.
• W2895516423 creator A5079844000 @default.
• W2895516423 creator A5087446982 @default.
• W2895516423 creator A5088930540 @default.
• W2895516423 date "2018-10-06" @default.
• W2895516423 modified "2023-10-15" @default.
• W2895516423 title "Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study" @default.
• W2895516423 cites W1968299736 @default.
• W2895516423 cites W1985849470 @default.
• W2895516423 cites W1999464994 @default.
• W2895516423 cites W2007126967 @default.
• W2895516423 cites W2056631765 @default.
• W2895516423 cites W2063391067 @default.
• W2895516423 cites W2073683299 @default.
• W2895516423 cites W2113170798 @default.
• W2895516423 cites W2113935263 @default.
• W2895516423 cites W2117569715 @default.
• W2895516423 cites W2124473529 @default.
• W2895516423 cites W2127776375 @default.
• W2895516423 cites W2132836850 @default.
• W2895516423 cites W2136290128 @default.
• W2895516423 cites W2156537375 @default.
• W2895516423 cites W2167578480 @default.
• W2895516423 cites W2462542285 @default.
• W2895516423 cites W2570532684 @default.
• W2895516423 doi "https://doi.org/10.1007/s00432-018-2764-8" @default.
• W2895516423 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6326003" @default.
• W2895516423 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30293117" @default.
• W2895516423 hasPublicationYear "2018" @default.
• W2895516423 type Work @default.
• W2895516423 sameAs 2895516423 @default.
• W2895516423 citedByCount "17" @default.
• W2895516423 countsByYear W28955164232019 @default.
• W2895516423 countsByYear W28955164232020 @default.
• W2895516423 countsByYear W28955164232021 @default.
• W2895516423 countsByYear W28955164232022 @default.
• W2895516423 countsByYear W28955164232023 @default.
• W2895516423 crossrefType "journal-article" @default.
• W2895516423 hasAuthorship W2895516423A5021186573 @default.
• W2895516423 hasAuthorship W2895516423A5035483620 @default.
• W2895516423 hasAuthorship W2895516423A5041685966 @default.
• W2895516423 hasAuthorship W2895516423A5055466296 @default.
• W2895516423 hasAuthorship W2895516423A5064970901 @default.
• W2895516423 hasAuthorship W2895516423A5073304157 @default.
• W2895516423 hasAuthorship W2895516423A5078996494 @default.
• W2895516423 hasAuthorship W2895516423A5079844000 @default.
• W2895516423 hasAuthorship W2895516423A5087446982 @default.
• W2895516423 hasAuthorship W2895516423A5088930540 @default.
• W2895516423 hasBestOaLocation W28955164231 @default.
• W2895516423 hasConcept C121608353 @default.
• W2895516423 hasConcept C126322002 @default.
• W2895516423 hasConcept C141071460 @default.
• W2895516423 hasConcept C167135981 @default.
• W2895516423 hasConcept C197934379 @default.
• W2895516423 hasConcept C2776256026 @default.
• W2895516423 hasConcept C2776611710 @default.
• W2895516423 hasConcept C2776694085 @default.
• W2895516423 hasConcept C2777063308 @default.
• W2895516423 hasConcept C2778248108 @default.
• W2895516423 hasConcept C2778496288 @default.
• W2895516423 hasConcept C2779561371 @default.
• W2895516423 hasConcept C2780073493 @default.
• W2895516423 hasConcept C2780091579 @default.
• W2895516423 hasConcept C2780668389 @default.
• W2895516423 hasConcept C2780739268 @default.
• W2895516423 hasConcept C71924100 @default.
• W2895516423 hasConcept C90924648 @default.
• W2895516423 hasConceptScore W2895516423C121608353 @default.
• W2895516423 hasConceptScore W2895516423C126322002 @default.
• W2895516423 hasConceptScore W2895516423C141071460 @default.
• W2895516423 hasConceptScore W2895516423C167135981 @default.
• W2895516423 hasConceptScore W2895516423C197934379 @default.
• W2895516423 hasConceptScore W2895516423C2776256026 @default.
• W2895516423 hasConceptScore W2895516423C2776611710 @default.
• W2895516423 hasConceptScore W2895516423C2776694085 @default.
• W2895516423 hasConceptScore W2895516423C2777063308 @default.
• W2895516423 hasConceptScore W2895516423C2778248108 @default.
• W2895516423 hasConceptScore W2895516423C2778496288 @default.
• W2895516423 hasConceptScore W2895516423C2779561371 @default.
• W2895516423 hasConceptScore W2895516423C2780073493 @default.
• W2895516423 hasConceptScore W2895516423C2780091579 @default.
• W2895516423 hasConceptScore W2895516423C2780668389 @default.
• W2895516423 hasConceptScore W2895516423C2780739268 @default.
• W2895516423 hasConceptScore W2895516423C71924100 @default.
• W2895516423 hasConceptScore W2895516423C90924648 @default.
• W2895516423 hasIssue "1" @default.
• W2895516423 hasLocation W28955164231 @default.
• W2895516423 hasLocation W28955164232 @default.
• W2895516423 hasLocation W28955164233 @default.
• W2895516423 hasLocation W28955164234 @default.

• next